| Schulze Muscular Dystrophy Ability Clinical Study (NCT05409079) | AbiliTech Medical Inc. | 2022-05-26 |
| A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice (NCT04475926) | Sarepta Therapeutics, Inc. | 2021-04-22 |
| MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants (NCT05102799) | Rigshospitalet, Denmark | 2021-04-01 |
| Limb-Girdle Muscular Dystrophy Type 2I in Norway (NCT03930628) | University Hospital of North Norway | 2020-01-06 |
| Biomarker Development in LGMD2i (NCT04202627) | ML Bio Solutions, Inc. | 2019-12-01 |
| A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I) (NCT03783923) | PTC Therapeutics | 2019-10-31 |
| Weekly Steroids in Muscular Dystrophy (NCT04054375) | Northwestern University | 2019-07-01 |
| Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) (NCT03981289) | Virginia Commonwealth University | 2019-06-14 |
| Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT02836418) | aTyr Pharma, Inc. | 2016-07-13 |
| MRI on Persons With Mutations in POMT2 Gene (LGMD2N) (NCT02759302) | Rigshospitalet, Denmark | 2016-04-01 |
| MRI and Muscle Involvement in Patients With Mutations in GMPPB (NCT02635321) | Rigshospitalet, Denmark | 2015-11-01 |
| Global FKRP Registry (NCT04001595) | Newcastle University | 2013-11-01 |
| Cell Therapy in Limb Girdle Muscular Dystrophy (NCT02245711) | Neurogen Brain and Spine Institute | 2010-12-01 |
| Cardiac Magnetic Resonance in Children With Muscular Dystrophy (NCT01081080) | Cooperative International Neuromuscular Research Group | 2010-04-01 |
| Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (NCT01126697) | Cooperative International Neuromuscular Research Group | 2010-02-01 |
| Cardiac Outcome Measures in Children With Muscular Dystrophy (NCT01066455) | Cooperative International Neuromuscular Research Group | 2010-01-01 |
| Congenital Muscle Disease Study of Patient and Family Reported Medical Information (NCT01403402) | Cure CMD | 2009-09-01 |
| Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy (NCT00873782) | University of North Carolina, Chapel Hill | 2009-03-01 |
| Stem Cell Therapy in Limb Girdle Muscular Dystrophy (NCT02050776) | Neurogen Brain and Spine Institute | 2008-12-01 |
| Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy (NCT00457912) | Nationwide Children's Hospital | 2005-06-01 |
| Study Evaluating MYO-029 in Adult Muscular Dystrophy (NCT00104078) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-02-01 |
| Molecular Analysis of Patients With Neuromuscular Disease (NCT00390104) | Boston Children's Hospital | 2002-01-01 |